Skip to content

Opening book details…

Can I read Two-Year Outcomes of Treat‐and‐Extend Intravitreal Aflibercept for Exudative Age-related Macular Degeneration: A Prospective Study on EtoBox?

Two-Year Outcomes of Treat‐and‐Extend Intravitreal Aflibercept for Exudative Age-related Macular Degeneration: A Prospective Study by Maruko, Ichiro; Ogasawara, Masashi; Yamamoto, Akiko; Itagaki, Kanako; Hasegawa, Taiji; Arakawa, Hisaya; Nakayama, Makiko; Koizumi, Hideki; Okada, Annabelle A.; Sekiryu, Tetsuju; Iida, Tomohiro is a Medicine article available to read on EtoBox.

What is Two-Year Outcomes of Treat‐and‐Extend Intravitreal Aflibercept for Exudative Age-related Macular Degeneration: A Prospective Study about?

## Purpose: To report the 2-year outcomes of intravitreal aflibercept injections (iais) in japanese patients with neovascular age-related macular degeneration (amd) using a 1-month adjusted treat-and-extend (tae) regimen. ## Design: Multicenter, prospective, nonrandomized, interventional study. ## Participants: Ninety-seven eyes of 97 patients with treatment-naive amd were studied at 3 tertiary ophthalmological institutions. ## Methods: The patients were treated with 3 consecutive monthly iais followed by the tae regimen with a 1-month adjustment for a maximum of 3 months. our tae regimen allowed us to shorten and extend the treatment intervals even after a 3-month or 1-month treatment interval, or both, were reached. best-corrected visual acuity (bcva), central retinal thickness (crt), and subfoveal choroidal thickness (sct) were analyzed. ## Main outcome measures: The mean changes in the bcva, crt, and sct from the baseline to 2 years after initiating the treatment were determined. in addition, the number of injections also was determined. ## Results: The mean bcva significantly improved from 0.27 logarithm of the minimum angle of resolution (logmar) units to 0.14 logmar at 2 yea

Who reads Two-Year Outcomes of Treat‐and‐Extend Intravitreal Aflibercept for Exudative Age-related Macular Degeneration: A Prospective Study?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Maruko, Ichiro; Ogasawara, Masashi; Yamamoto, Akiko; Itagaki, Kanako; Hasegawa, Taiji; Arakawa, Hisaya; Nakayama, Makiko; Koizumi, Hideki; Okada, Annabelle A.; Sekiryu, Tetsuju; Iida, Tomohiro
Publisher
Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 2468-6530)
Published
2020
Language
EN
Field
Medicine (Health Sciences)

More by Maruko, Ichiro; Ogasawara, Masashi; Yamamoto, Akiko; Itagaki, Kanako; Hasegawa, Taiji; Arakawa, Hisaya; Nakayama, Makiko; Koizumi, Hideki; Okada, Annabelle A.; Sekiryu, Tetsuju; Iida, Tomohiro

Browse all works by Maruko, Ichiro; Ogasawara, Masashi; Yamamoto, Akiko; Itagaki, Kanako; Hasegawa, Taiji; Arakawa, Hisaya; Nakayama, Makiko; Koizumi, Hideki; Okada, Annabelle A.; Sekiryu, Tetsuju; Iida, Tomohiro